{
    "2018-02-06": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Nordisk's Dichotomy Abounds",
                "features": {
                    "keywords": [
                        "Nordisk",
                        "Dichotomy",
                        "Abounds"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "FOCUS-In diabetes war, Novo Nordisk aims to break mould with new pill",
                "features": {
                    "keywords": [
                        "diabetes",
                        "Novo",
                        "Nordisk",
                        "new pill"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-10",
                "original_text": "Analystsâ€™ Recommendations for Novartis after Its 4Q17 Earnings",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommendations",
                        "Novartis",
                        "4Q17",
                        "Earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}